Cas:59183-50-5 3-(3,4-Dimethoxyphenyl)-6-methoxy-4-oxo-4H-chromen-7-yl β-D-gluco pyranoside manufacturer & supplier

Chemical Name:3-(3,4-Dimethoxyphenyl)-6-methoxy-4-oxo-4H-chromen-7-yl β-D-gluco pyranoside

CAS.NO:59183-50-5

Synonyms:3-(3,4-Dimethoxyphenyl)-6-methoxy-4-oxo-4H-chromen-7-yl β-D-gluco pyranoside

Molecular Formula:C₂₄H₂₆O₁₁

Molecular Weight:490.45700

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:157.28000

Exact Mass:490.14800

LogP:0.66450

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-(3,4-Dimethoxyphenyl)-6-methoxy-4-oxo-4H-chromen-7-yl β-D-gluco pyranoside chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(3,4-Dimethoxyphenyl)-6-methoxy-4-oxo-4H-chromen-7-yl β-D-gluco pyranoside physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(3,4-Dimethoxyphenyl)-6-methoxy-4-oxo-4H-chromen-7-yl β-D-gluco pyranoside Use and application,3-(3,4-Dimethoxyphenyl)-6-methoxy-4-oxo-4H-chromen-7-yl β-D-gluco pyranoside technical grade,usp/ep/jp grade.

Related News: According to the 2013-2018 New Drug Review Summary report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years. 3-(3,4-Dimethoxyphenyl)-6-methoxy-4-oxo-4H-chromen-7-yl β-D-gluco pyranoside manufacturer A week before Eli Lilly (LLY.N) disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing there, according to a company memo reviewed by Reuters. 3-(3,4-Dimethoxyphenyl)-6-methoxy-4-oxo-4H-chromen-7-yl β-D-gluco pyranoside supplier In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn. 3-(3,4-Dimethoxyphenyl)-6-methoxy-4-oxo-4H-chromen-7-yl β-D-gluco pyranoside vendor Separately, Europe’s drug regulator said on Friday that batches of J&J COVID-19 vaccine made for the region around the time the contamination issues were revealed at the Baltimore plant would, as a precaution, not be used. 3-(3,4-Dimethoxyphenyl)-6-methoxy-4-oxo-4H-chromen-7-yl β-D-gluco pyranoside factory In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.